Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.6994
+0.0094 (1.36%)
Oct 30, 2025, 4:00 PM EDT - Market closed
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $53.75 million as of October 31, 2025. Its market cap has decreased by -26.23% in one year.
Market Cap
53.75M
Enterprise Value
33.42M
1-Year Change
-26.23%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $226.28M to $53.75M, a decrease of -76.25%. That is a compound annual growth rate of -16.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 53.02M | -23.21% |
| Dec 31, 2024 | 69.05M | -42.03% |
| Dec 29, 2023 | 119.13M | -2.89% |
| Dec 30, 2022 | 122.67M | -65.85% |
| Dec 31, 2021 | 359.22M | -5.17% |
| Dec 31, 2020 | 378.78M | 3.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |